DK165785B - PROCEDURE FOR THE PREPARATION OF TRIPHENYL BUTEN DERIVATIVES AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND INTERMEDIATES FOR USING THE PROCEDURE - Google Patents

PROCEDURE FOR THE PREPARATION OF TRIPHENYL BUTEN DERIVATIVES AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND INTERMEDIATES FOR USING THE PROCEDURE Download PDF

Info

Publication number
DK165785B
DK165785B DK236683A DK236683A DK165785B DK 165785 B DK165785 B DK 165785B DK 236683 A DK236683 A DK 236683A DK 236683 A DK236683 A DK 236683A DK 165785 B DK165785 B DK 165785B
Authority
DK
Denmark
Prior art keywords
triphenyl
reaction
toluene
mixture
solvent
Prior art date
Application number
DK236683A
Other languages
Danish (da)
Other versions
DK165785C (en
DK236683D0 (en
DK236683A (en
Inventor
Reijo J Toivola
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK236683D0 publication Critical patent/DK236683D0/en
Publication of DK236683A publication Critical patent/DK236683A/en
Publication of DK165785B publication Critical patent/DK165785B/en
Application granted granted Critical
Publication of DK165785C publication Critical patent/DK165785C/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)

Description

iin

DK 165785BDK 165785B

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af (Z)-l,2-difenyl-l-£4-[2-(N,N-dimetyl-amino)-ætoxy]-fenyl^-l-buten eller tamoxifen med nedenstående formel I, eller syreadditionssalte deraf og mellemprodukter 5 til brug ved fremgangsmåden.The present invention relates to a particular process for the preparation of (Z) -1,2-diphenyl-1- [4- [2- (N, N-dimethylamino) -ethoxy] -phenyl] -1-butene or tamoxifen with Formula I below, or acid addition salts thereof and intermediates 5 for use in the process.

CH ..CH ..

/ 3/ 3

OCH-,CH_,NOCH-, CH_, N

φ "c"s I 2 CH3φ "c" s I 2 CH3

Tamoxifen har antiøstrogen virkning. På grund af denne ^ egenskab bruges forbindelsen terapeutisk til behandling af hormonafhængig brystkræft.Tamoxifen has antiestrogenic effect. Because of this property, the compound is used therapeutically to treat hormone-dependent breast cancer.

Fremstillingen af tamoxifen med formlen I er beskrevet i fire patentskrifter (GB 1.013.907 og 1.354.939, AT 347.929 og DE 2.704.690), hvor der er angivet fire fremgangsmåder 2q til fremstilling deraf. Tre af disse processer (GB 1.013.907, AT 347.929 og DE 2.704.690) omfatter en Grignard- eller tilsvarende reaktion, der er vanskelig at udføre i industriel målestok. Den fjerde proces (GB 1.354.939) omfatter ikke nogen Grignard-reaktion, men processens sidste trin er i andre hen-25 seender vanskelig at gennemføre. Der bruges som reagens nemlig enten kalium- eller natriumamid og som opløsningsmiddel enten flydende ammoniak eller dimetylformamid. Når der bruges ammoniak er temperaturen mellem -40 og -20°C og når der bruges dimetylformamid 120-150°C.The preparation of tamoxifen of formula I is described in four patents (GB 1,013,907 and 1,354,939, AT 347,929 and DE 2,704,690), which disclose four methods 2q for their preparation. Three of these processes (GB 1,013,907, AT 347,929 and DE 2,704,690) include a Grignard or equivalent reaction that is difficult to perform on an industrial scale. The fourth process (GB 1,354,939) does not include any Grignard reaction, but the last step of the process is difficult to complete in other respects. It is used as a reagent namely either potassium or sodium amide and as solvent either liquid ammonia or dimethylformamide. When ammonia is used, the temperature is between -40 and -20 ° C and when dimethylformamide is used 120-150 ° C.

3q Foruden dette må i hver af de fire i patentskrifterne beskrevne processer tamoxifenkernen opbygges stump for stump i et antal succesive trin. Det samme gælder a-ætyldesoxybenzo-iner som bruges som udgangsmaterialer i henhold til patentskrifterne. Endelig kan det nævnes at med undtagelse af den ene sidekæde i en af processerne må der i alle fremgangsmåder-3 ^ O o ne bruges enten høje (>>100 C) eller lave (<<0 C) temperaturer i mindst ét reaktionstrin.3q In addition to this, in each of the four processes described in the patent documents, the tamoxifen core must be built blunt by blunt in a number of successive steps. The same applies to α-ethylene oxybenzoins which are used as starting materials according to the patent specifications. Finally, it can be mentioned that with the exception of one side chain in one of the processes, either all high (>> 100 C) or low (<< 0 C) temperatures must be used in at least one reaction step in all processes.

DK 165785 BDK 165785 B

22

Ved fremgangsmåden ifølge den foreliggende opfindelse fremstilles tamoxifen uden nogen Grignard-reaktion og ved temperaturer på 0-100°C. Der kan imidlertid om ønsket bruges lavere eller højere temperaturer.Tamoxifenkernen selv frem-5 stilles meget let og i modsætning til hvad tilfældet er ved de kendte fremgangsmåder direkte i ét trin i et udbytte på 60-80% ud fra kanelaldehyd (II) og 4-[2-(N,N-dimetylamino)-ætoxy]-benzofenon (IV). Derefter opbygges tamoxifenkernen i 2-5 meget simple og let gennemførte reaktionstrin hvorved 10 tamoxifen fås som slutprodukt. Disse reaktioner forløber med praktisk talt kvantitative udbytter uden bireaktioner. Da der imidlertid dannes 1/3 af (E)-isomeren i dehydratiserings-trinnet ligesom i de kendte processer, er det teoretiske udbytte kun ca. 67%. Desuden nedsætter tab, primært i forbin-•]5 delse med fjernelse (E)-isomeren, udbyttet fra 67% til ca.In the process of the present invention, tamoxifen is prepared without any Grignard reaction and at temperatures of 0-100 ° C. However, if desired, lower or higher temperatures may be used. The tamoxifen core itself is prepared very readily and contrary to the known processes directly in one step in a 60-80% yield from cinnamaldehyde (II) and 4 - [2- (N, N-dimethylamino) -ethoxy] -benzophenone (IV). Thereafter, the tamoxifen core is built up in 2-5 very simple and easily completed reaction steps to obtain 10 tamoxifen as the final product. These reactions proceed with virtually quantitative yields without side reactions. However, as 1/3 of the (E) isomer is formed in the dehydration step just as in the known processes, the theoretical yield is only approx. 67%. In addition, loss, primarily in connection with the removal (E) isomer, reduces the yield from 67% to approx.

50%. Med andre ord er udbyttet af (Z)-tamoxifen med formel I, beregnet ud fra den anvendte mængde 4-[2-(N,N~dimetylamino)-ætoxy]-benzofenon med formel IV 30-40%.50%. In other words, the yield of (Z) -amoxifene of formula I, calculated from the amount of 4- [2- (N, N-dimethylamino) -ethoxy] -benzophenone of formula IV is 30-40%.

Fremgangsmåden ifølge opfindelsen til fremstilling af 20 tamoxifen eller et syreadditionssalt deraf er ejendommelig ved, at et trifenylbutenderivat med formlen OCH^CH.N^f 0 Γ ^CH3The process of the invention for the preparation of tamoxifen or an acid addition salt thereof is characterized in that a triphenylbutene derivative of the formula OCH

25 Q VHI25 Q VHI

Or-OOr O

CH-, ifi2x 30 hvor X er en funktionel gruppe såsom F, Cl, Br, I eller ?CH-, ifi2x 30 where X is a functional group such as F, Cl, Br, I or?

-O-S-R-O-S-R

& hvor R er 4-tolyl eller metyl, reduceres med et metalhydrid-reduktionsmiddel såsom litiumaluminiumhydrid i f.eks. tetra-hydrofuran ved forhøjet temperatur, natriumborhydrid ved for- 35 3& where R is 4-tolyl or methyl is reduced by a metal hydride reducing agent such as lithium aluminum hydride in e.g. tetrahydrofuran at elevated temperature, sodium borohydride at form 3

DK 165785BDK 165785B

højet temperatur eller i et organisk opløsningsmiddel, såsom dimethylsulfoxid, eller ved anvendelse af faseoverføringsteknik, hvor den organiske fase f.eks. er toluen, eller natriumbis- ( 2-metoxyætoxy) -aluminiumdihydrid f.eks. i toluen ved for-5 højet temperatur.elevated temperature or in an organic solvent such as dimethyl sulfoxide, or using phase transfer technique, wherein the organic phase e.g. is toluene, or sodium bis (2-methoxyethoxy) aluminum dihydride e.g. in toluene at elevated temperature.

Ved fremgangsmåden ifølge opfindelsen bruges der som udgangsmateriale kanelaldehyd (II) og 4-[2-(N,N-dimetylami-no)-ætoxy]-benzofenon med formel IV. Først hydroalumineres kanelaldehyd med formel IIThe process of the invention uses as starting material cinnamaldehyde (II) and 4- [2- (N, N-dimethylamino) -ethoxy] -benzophenone of formula IV. First, cinnamal aldehyde of formula II is hydroaluminated

1010

<^^y_CHCHCH0 II<^^ y_CHCHCH0 II

hvorved der dannes et Al-kompleks med formel III: 15 " . /CH2CvH2 /TVdH b W \A1/ m NCH2CH2 wto form an Al complex of formula III: 15 "/ CH2CvH2 / TVdH b W \ A1 / m NCH2CH2 w

20 Når man omsætter dette Al-kompleks med benzofenonderivatet IV20 When reacting this Al complex with the benzophenone derivative IV

ch3 OCH^CH_N'^ Φ ^ - dannes der 1,2-difenyl-l-{4-[2-(Ν,Ν-dimetylamino)-ætoxy]-fe-nyl}-butan-l,4-diol eller trifenyldiol med formel V: 30 CH-, / ^CH3 OCH3 CHN3 + - 1,2-diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] phenyl} -butane-1,4-diol or triphenyldiol is formed of formula V: 30 CH-, / ^

0CHnCHo*T0CHnCHo * T

φ 2oh ch2ohφ 2oh ch2oh

DK 165785 BDK 165785 B

4 I næste trin dehydratiseres trifenyldiolen V til dannelse af 4-acetoxy-l,2-difenyl-l-{4-[2-(Ν,Ν-dimetylamino)-ætoxy]-4 In the next step, the triphenyl diol V is dehydrated to give 4-acetoxy-1,2-diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] -

fenyl} -1-buten eller trifenylacetat med formel VIphenyl} -1-butene or triphenyl acetate of formula VI

CH, 3CH, 3

ς OCH-.CH,Nς OCH-.CH, N

5 I 2 2 \ 1 CH..5 I 2 2 \ 1 CH.

00

O-r-OO-R-O

,° <p2 J, ° <p2 J

CH2OCCH3 I følgende trin hydrolyseres trifenylacetatet VI til 1,-2-di-fenyl-l-£4-[ 2- (Ν,Ν-dimetylamino) -ætoxy ] -fenyl}-l-buten-4-ol ^ eller trifenylalkoholen VII: CH-, / 3CH2OCCH3 In the following steps, the triphenyl acetate VI is hydrolyzed to 1,2-di-phenyl-1- [4- [2- (Ν, Ν-dimethylamino) -ethoxy] -phenyl} -1-buten-4-ol ^ or triphenyl alcohol VII : CH-, / 3

OCH,CH,NOCH, CH, N

i 2 2 \ L X CH-, » ni 2 2 \ L X CH-, »n

Or-OOr O

CH, I 2CH, I 2

CH2OHCH 2 OH

2525

Hydroxygruppen i trifenylalkoholen VII substitueres med halogen, hvorved der dannes 4-halogen-l,2-difenyl-l-{4-[2-(N,N-dimetylamino)-ætoxy]-fenyl}-l-buten, dvs. trifenylhalogenidet VIII hvor X betegner F, Cl, Br eller I: CH, 30 OCH,CH,N^ 1 2 2 ^«3 0 OT03 35 CH2 ch2-xThe hydroxy group of triphenyl alcohol VII is substituted with halogen to give 4-halogen-1,2-diphenyl-1- {4- [2- (N, N-dimethylamino) -ethoxy] -phenyl} -1-butene, i.e. the triphenyl halide VIII where X represents F, Cl, Br or I: CH, OCH, CH, N ^ 1 2 2 ^ '30 O0 O3 CH2 ch2-x

DK 165785BDK 165785B

5 · I stedet kan man fremstille en sulfonsyreester ud fra trifenyl- alkoholen VII, hvorved der vindes 4-sulfonyloxy-l,2-difenyl- 1 ~{*4 — [ 2-(N,N-dimetylamino)-æt0xy]-fenyl}--l--buten eller trife- nylsulfonatet IX hvor R betegner 4-tolyl eller metyl:Instead, a sulfonic acid ester can be prepared from the triphenyl alcohol VII to give 4-sulfonyloxy-1,2-diphenyl-1- [{4 - [2- (N, N-dimethylamino) -ethoxy] -phenyl } - 1 - butene or trifinylsulfonate IX where R represents 4-tolyl or methyl:

5 ^CH5 ^ CH

OCH-CH0N^ JOCH-CHON ^ J

φ "φ "

γ-λ \ r~\ IXγ-λ \ r ~ \ IX

,o Otc~0 CH_ 1 0 li, o Otc ~ 0 CH_ 1 0 li

CH-OSRCH-OSR

2 II2 II

o 15o 15

Trifenylhalogenider med formel VIII kan også fremstilles ud fra trifenylsulfonater IX eller ud fra et andet trifenylhalo-genid VIII.Triphenyl halides of formula VIII may also be prepared from triphenylsulfonates IX or from another triphenyl halide VIII.

I sidste trin reduceres trifenylhalogenidet VIII eller trifenylsulfonatet IX til tamoxifen I.In the final step, the triphenyl halide VIII or triphenylsulfonate IX is reduced to tamoxifen I.

2020

Trifenyldiolen V kan også dehydratiseres på en sådan måde at der dannes 2,3-difenyl-2-{4-[2-(Ν,Ν-dimetylamino)-ætoxyj-fenyl]-tetrahydrofuran, dvs. trifenylfuranforbindelsen X: ^CH3The triphenyl diol V can also be dehydrated in such a way as to form 2,3-diphenyl-2- {4- [2- (Ν, dim-dimethylamino) -ethoxy] -phenyl] -tetrahydrofuran, i.e. the triphenylfuran compound X: ^ CH3

25 0CHoCH„N25 0CHoCH „N

1 CH31 CH3

QQ

O/'vOO / 'VO

30 Når tetrahydrofuranringen i trifenylfuranet X åbnes under passende betingelser vindes trifenylacetat VI. Åbningen af tetrahydrofuranringen såvel som dehydratiseringen af trifenyl-25 diol V kan også gennemføres på en sådan måde at man direkte vinder trifenylalkoholen VII.When the tetrahydrofuran ring in the triphenylfuran X is opened under appropriate conditions, triphenyl acetate VI is obtained. The opening of the tetrahydrofuran ring as well as the dehydration of triphenyldiol V can also be accomplished in such a way that the triphenyl alcohol VII is directly obtained.

DK 165785 BDK 165785 B

66

Dehydratiseringen og omdannelsen af den primære hydro-xygruppe til et halogenatom eller en sulfonyloxygruppe kan også ske i modsat rækkefølge af den ovenfor beskrevne. Ud fra trifenyltiolen V kan man således fremstille enten 4-halo-5 gen-1,2-dif enyl-l-{.4-[ 2- (Ν,Ν-dimetylamino) -ætoxy ] -fenyl} -bu-tan-l-ol eller hydroxyhalogenidet XI: .CH,The dehydration and conversion of the primary hydroxy group to a halogen atom or a sulfonyloxy group may also occur in the reverse order of that described above. Thus, from the triphenylthiol V can be prepared either 4-halo-5-1,2-diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] -phenyl} -butane 1-ol or the hydroxy halide XI: .CH,

0CHoCHotr J0CHoCHotr J

Λ "3 ,0 Lj3 "3, 0 Lj

Ln n t i ^ CH2hal ^ hvor hal betegner F, Cl, Br eller I, eller hydroxysulfonatet XIX, nemlig 4-sulfonyloxy-l, 2-dif enyl-l-£4-[ 2-(Ν,Ν-dimetylamino) -ætoxy]-fenylj-butan-l-ol: auLn nti ^ CH 2 hal 2 wherein hal represents F, Cl, Br or I, or the hydroxysulfonate XIX, namely 4-sulfonyloxy-1,2-diphenyl-1- [4- (2-, Ν-dimethylamino) -ethoxy] -phenylj-butan-1-ol: au

OCH-CIUNCOCH-CIUNC

20 I 2 ^CH, p /Λ-.ΟΗ XI120 I 2 ^ CH, p /Λ-.ΟΗ XI1

W CH,0H WW CH, 0H W

25 I 2 ΐ25 I 2 ΐ

CH20-cj-:RCH20-C₅-: R

OISLAND

hvor R betegner 4-tolyl eller metyl. Når hydroxyhalogenidet ^ XI eller hydroxysulfonatet XII dehydratiseres vinder man tri-fenylhalogenidet VIII eller det tilsvarende trifenylsulfonat IX.wherein R represents 4-tolyl or methyl. When the hydroxy halide XI or hydroxy sulfonate XII is dehydrated, the triphenyl halide VIII or the corresponding triphenylsulfonate IX is obtained.

Trifenylhalogenider VIII kan endvidere fremstilles direkte i et reaktionstrin ud fra trifenyldiolen V såvel som ud fra trifenylfuranet X. Faktisk er denne fremgangsmåde til dehydratisering af trifenyldiolen V den allerbedste og mest praktiske fordi man herved kan udelade et eller flere reaktionstrin og således nedsætte reaktionsfølgen til tre trin. Frem-Furthermore, triphenyl halides VIII can be prepared directly in a reaction step from the triphenyl diol V as well as from the triphenylfuran X. In fact, this process for dehydrating the triphenyl diol V is the very best and most practical because it can omit one or more reaction steps and thus reduce the reaction sequence to three steps. . Flow

DK 165785 BDK 165785 B

7 gangsmåden til fremstilling af tamoxifen er med andre ord mest hensigtsmæssig og gunstig at udføre i henhold til følgende reaktionsserie: I første trin fremstilles trifenyldio-len V ud fra kanelaldehyd II og 4-[2-(N,N-dimetylamino)~ 5 ætoxy]-benzofenon IV. I andet trin dehydratiseres trifenyl-diolen V til som slutprodukt at give et trifenylhalogenid XI, der derpå reduceres i tredje og sidste reaktionstrin til tamoxifen I.In other words, the procedure for preparing tamoxifen is most convenient and advantageous to carry out according to the following reaction series: In the first step, the triphenyldiol V is prepared from cinnamaldehyde II and 4- [2- (N, N-dimethylamino) ~ 5 ] -benzophenone IV. In the second step, the triphenyl diol V is dehydrated to give as a final product a triphenyl halide XI which is then reduced in the third and final reaction step to tamoxifen I.

Alle mellemprodukterne V-XIII ved den foreliggende 10 reaktionsserie er hidtil ukendte forbindelser.All of the intermediates V-XIII of the present reaction series are novel compounds.

Opfindelsen angår derfor også et (Z)-1,2-difenyl-1-£4-[2-(N,N-dimetylamino)-ætoxy]-fenyl}'-1-butenderivat med formlen 15 ^CH3 13 OCH-CH^N-^ I 1 1 ^CH3 vin O ^c—^3 20 CH- I 2The invention therefore also relates to a (Z) -1,2-diphenyl-1- [4- [2- (N, N-dimethylamino) -ethoxy] -phenyl} -1-butene derivative of the formula 15 ^ N- ^ I 1 1 ^ CH3 wine O ^ c— ^ 3 20 CH- I 2

CH2XCH 2 X

C) hvor X betegner F, Cl, Br, I eller -O-S-R, hvor R er 4-tolyl & 25 eller metyl til brug som udgangsmateriale ved fremgangsmåden ifølge krav 1.C) wherein X represents F, Cl, Br, I or -O-S-R, where R is 4-tolyl & 25 or methyl for use as starting material in the process of claim 1.

Hydroalumineringen af kanelaldehydet II udføres med et eller andet aluminiumhydrid-reduktionsmiddel, fx litiumalu-miniumhydrid eller natrium-bis-(2-metoxyætoxy)-aluminiumdihy-30 drid, og det dannede aluminiumkompleks III omsættes med 4- [2-(N,N-dimetylamino)-ætoxy)-benzofenonet IV. Reaktionen udføres fortrinsvis ved stuetemperatur i fx et æter- eller et kulbrinte-opløsningsmiddel eller en blanding deraf. Som eksempel på et æter-opløsningsmiddel kan nævnes tetrahydrofu-The hydroalumination of cinnamal aldehyde II is carried out with some aluminum hydride reducing agent, for example lithium aluminum hydride or sodium bis (2-methoxyethoxy) aluminum dihydride, and the resulting aluminum complex III is reacted with 4- [2- (N, N- the dimethylamino-ethoxy-benzophenone IV. The reaction is preferably carried out at room temperature in, for example, an ether or a hydrocarbon solvent or a mixture thereof. An example of an ether solvent may be mentioned tetrahydrofuran.

DK 165785 BDK 165785 B

8 ran og på en kulbrinte toluen.8 robberies and on a hydrocarbon toluene.

Trifenyldiolen V kan dehydratiseres på mange forskellige måder, bl.a. med en sur katalysator enten i et alkoholisk opløsningsmiddel eller i en organisk syre eller med en bian-5 ding af et syreanhydrid og et syreklorid.The triphenyl diol V can be dehydrated in many different ways, including with an acidic catalyst either in an alcoholic solvent or in an organic acid or with a mixture of an acid anhydride and an acid chloride.

Når man bruger en blanding af eddikesyreanhydrid og acetylklorid udføres reaktionen fortrinsvis ved en temperatur på 80-100°C på følgende måde: Først omsættes trifenyldiolen V med eddikesyreanhydrid 10 til dannelse af 4-acetoxy-l,2-difenyl-l-{4-[2-(N,N-dimetylami-no)-ætoxy]-fenylj-butan-l-ol eller hydroxyacetatet XIII: CH,When using a mixture of acetic anhydride and acetyl chloride, the reaction is preferably carried out at a temperature of 80-100 ° C as follows: First, the triphenyl diol V is reacted with acetic anhydride 10 to form 4-acetoxy-1,2-diphenyl-1- {4- [2- (N, N-dimethylamino) -ethoxy] -phenyl] -butan-1-ol or the hydroxyacetate XIII: CH

OCH-CH-N^ JAND-CH-N ^ J

Φ2 2 CH-,Φ2 2 CH-,

XIIIXIII

I 2 0 20 CH20-i-CH3I 20 CH 2 O-CH 3

Derefter tilsættes der acetylklorid, hvorved hydroxyacetat XIII dehydratiseres.Acetyl chloride is then added to dehydrate hydroxy acetate XIII.

Hydrolyse af det dannede trifenylacetat VI udføres i et passende opløsningsmiddel under enten sure, alkaliske 25 eller neutrale betingelser. Ved sur og alkalisk hydrolyse bruges der hensigtsmæssigt et alkoholisk opløsningsmiddel, fx ætanol, og reaktionen udføres enten ved blandingens kogepunkt eller ved lavere temperatur. Ved alkalisk hydrolyse kan fx natriumhydroxyd bruges som katalysator og ved sur hy-30 drolyse fx saltsyre.Hydrolysis of the resulting triphenyl acetate VI is carried out in a suitable solvent under either acidic, alkaline or neutral conditions. In acidic and alkaline hydrolysis, an alcoholic solvent, e.g. ethanol, is conveniently used and the reaction is carried out either at the boiling point of the mixture or at a lower temperature. For example, in alkaline hydrolysis, sodium hydroxide can be used as a catalyst and in acidic hydrolysis, for example hydrochloric acid.

Trifenylhalogeniderne VIII fremstilles ud fra trifenyl-alkohol VII på fx følgende måder: Ved behandling af trifenyl-alkoholen VII i et passende opløsningsmiddel med fx diætylami-nosvovltrifluorid ( (C2Hj-) ^SF.^ dannes -der trifenylfluoridet VIII (X = 35 F). Som opløsningsmiddel kan der bl.a. bruges halogenerede kulbrinter eller ætere og som specielle eksempler kan nævnes metylenklorid og dimetoxyætan. Reaktionen udføres fortrinsvis 9The triphenyl halides VIII are prepared from triphenyl alcohol VII, for example in the following ways: By treating the triphenyl alcohol VII in a suitable solvent with, for example, diethylamino nosulfur trifluoride ((C 2 H 2 As a solvent, inter alia, halogenated hydrocarbons or ethers may be used and as special examples may be mentioned methylene chloride and dimethoxyethane.

DK 165785BDK 165785B

ved stuetemperatur eller ved lavere temperatur.at room temperature or at lower temperature.

Ved behandling af trifenylalkoholen VII i et passende opløsningsmiddel med fx tionylklorid eller trifenylfosfin-kulstoftetraklorid-reagens dannes trifenylkloridet VIII (X = 5 Cl). Ved anvendelse af tionylklorid kan reaktionen udføres i fx kloroform, og når der bruges trifenylfosfin-kulstoftetra-klorid-reagenset kan der fx bruges acetonitril eller en blanding af acetonitril og kulstoftetraklorid. Reaktionen gennemføres mest hensigtsmæssigt ved reaktionsblandingens kogepunkt 10 eller ved lavere temperatur. Ved behandling af trifenylalkoholen VII i et passende opløsningsmiddel med fx fosfortribromid eller trifenylfosfin-kulstoftetrabromid dannes på tilsvarende måde trifenylbromidet VIII (X = Br). Når der bruges fosfortribromid kan reaktionen fx udføres i metylenklorid, og når der 15 bruges trifenylfosfin-kulstoftetrabromid-reagenset fx i acetonitril eller en blanding af acetonitril og metylenklorid.When treating the triphenyl alcohol VII in a suitable solvent with, for example, thionyl chloride or triphenylphosphine carbon tetrachloride reagent, the triphenyl chloride VIII is formed (X = 5 Cl). Using thionyl chloride, the reaction can be carried out in, for example, chloroform, and when using the triphenylphosphine carbon tetrachloride reagent, for example, acetonitrile or a mixture of acetonitrile and carbon tetrachloride can be used. The reaction is most conveniently carried out at the boiling point of the reaction mixture or at a lower temperature. When treating the triphenyl alcohol VII in a suitable solvent with, for example, phosphorus tribromide or triphenylphosphine carbon tetrabromide, the triphenyl bromide VIII (X = Br) is similarly formed. For example, when phosphorus tribromide is used, the reaction can be carried out in methylene chloride and when the triphenylphosphine carbon tetrabromide reagent is used, for example, in acetonitrile or a mixture of acetonitrile and methylene chloride.

I begge tilfælde udføres reaktionen fortrinsvis ved ca. stuetemperatur. Når man behandler trifenylalkoholen VII i et passende opløsningsmiddel med fx trifenylfosfit-metojodid 20 dannes trifenyljodidet VIII (X = I). Som opløsningsmiddel kan der bl.a. bruges hexametylfosfortriamid og som reaktionstemperatur stuetemperatur. Trifenylhalogeniderne VIII kan tillige omdannes til andre trifenylhalogenider VIII ved tilbagesvaling eller opvarmning deraf i et passende opløsnings-25 middel sammen med fx et alkalimetal- eller jordalkalimetalhalo-genid.In both cases, the reaction is preferably carried out at ca. room temperature. When treating triphenyl alcohol VII in a suitable solvent with, for example, triphenylphosphite methiodide 20, the triphenyl iodide VIII is formed (X = I). As a solvent, hexamethylphosphorous triamide is used and as the reaction temperature room temperature. The triphenyl halides VIII can also be converted to other triphenyl halides VIII by refluxing or heating them in a suitable solvent together with, for example, an alkali metal or alkaline earth metal halide.

På denne måde kan der fx ud fra trifenylkloridet VIII (X = Cl) fremstilles trifenylbromidet VIII (X = Br), og ud fra trifenylbromidet VIII (X = Br) kan man fremstille trifenyl-30 jodidet VIII (X = I). Som opløsningsmiddel kan der fx bruges N-metyl-2-pyrrolidon. Trifenylhalogenider VIII kan ligeledes fremstilles ud fra trifenylsulfonater IX ved tilbagesvaling eller opvarmning deraf i et passende opløsningsmiddel sammen med fx et alkalimetal- eller jordalkalimetalhalogenid. På 35 denne måde kan man fx ud fra trifenyltosylatet IX (R = 4-to-lyl) fremstille trifenyljodidet VIII (X = I). Reaktionen udføres fortrinsvis med anvendelse af natriumjodid som reagens og kogende acetone som opløsningsmiddel.In this way, for example, the triphenyl chloride VIII (X = Cl) can be prepared from the triphenyl bromide VIII (X = Br) and from the triphenyl bromide VIII (X = Br) the triphenyl iodide VIII (X = I) can be prepared. As a solvent, for example, N-methyl-2-pyrrolidone can be used. Triphenyl halides VIII can also be prepared from triphenyl sulfonates IX by refluxing or heating them in a suitable solvent together with, for example, an alkali metal or alkaline earth metal halide. In this way, for example, from the triphenyl tosylate IX (R = 4-toyl) the triphenyl iodide VIII (X = I) can be prepared. The reaction is preferably carried out using sodium iodide as a reagent and boiling acetone as the solvent.

DK 165785 BDK 165785 B

1010

Trifenylsulfonaterne IX fremstilles ud fra trifenylal-koholen VII fx ved følgende processer: Når man behandler tri-fenylalkolen VII med 4-toluensulfonsyreklorid under passende betingelser dannes trifenyltosylatet IX (R = 4-tolyl). Reaktio-5 nen kan udføres enten.'i et organisk opløsningsmiddel, fx py-ridin, i en opløsningsmiddelblanding eller ved faseoverføringsteknik under anvendelse af fx toluen som organisk opløsningsmiddel. Når reaktionen udføres i pyridin er det fordelagtigt at bruge en temperatur i nærheden af 0°C. Når der anven-10 des faseoverføringsteknik udføres reaktionen fortrinsvis ved ca. stuetemperatur. Når man behandler trifenylalkoholen VII med metansulfonsyreklorid ved passende betingelser dannes der tilsvarende trifenylmesylatet IX (R = metyl). Reaktionen kan udføres enten i et organisk opløsningsmiddel, fx pyridin 15 eller en blanding af metylenklorid og triætylamin, eller ved faseoverføringsteknik under anvendelse af fx metylenklorid som organisk opløsningsmiddel. I begge tilfælde udføres reaktionen fortrinsvis ved en temperatur i nærheden af 0°C.The triphenylsulfonates IX are prepared from the triphenylalcohol VII, for example, by the following processes: When treating the triphenyl alcohol VII with 4-toluenesulfonic acid chloride under appropriate conditions, the triphenyl tosylate IX is formed (R = 4-tolyl). The reaction can be carried out either in an organic solvent, for example pyridine, in a solvent mixture or by phase transfer technique using, for example, toluene as an organic solvent. When the reaction is carried out in pyridine, it is advantageous to use a temperature in the vicinity of 0 ° C. When phase transfer technique is used, the reaction is preferably carried out at ca. room temperature. When treating the triphenyl alcohol VII with methanesulfonic acid chloride under appropriate conditions, the corresponding triphenyl mesylate IX (R = methyl) is formed. The reaction can be carried out either in an organic solvent, for example pyridine 15 or a mixture of methylene chloride and triethylamine, or by phase transfer technique using, for example, methylene chloride as an organic solvent. In either case, the reaction is preferably carried out at a temperature in the vicinity of 0 ° C.

Trifenylhalogeniderne VIII reduceres til tamoxifen 20 I fx med et metalhydrid-reduktionsmiddel, katalytisk, ved hjælp af et opløst metal, via et mellemprodukt af Grignard-typen eller ved desulforering af en tioæter fremstillet ud fra et halogenid.The triphenyl halides VIII are reduced to tamoxifen 20 I, for example, with a metal hydride reducing agent, catalytically, by a dissolved metal, via a Grignard-type intermediate or by desulphoring a thioether prepared from a halide.

Som eksempler på brugbare metalhydrid-reduktionsmidler 25 kan bl.a. nævnes litiumaluminiumhydrid, natriumborhydrid, natrium-bis- (2-metoxyætoxy·) -aluminiumdihydrid, natriumcyanbor-hydrid og tributyltinhydrid. Når der bruges litiumaluminiumhydrid er fx ætere eller kulbrinter såsom tetrahydrofuran eller toluen eller blandinger deraf brugbare som opløsningsmidler.As examples of useful metal hydride reducing agents 25 mention is made of lithium aluminum hydride, sodium borohydride, sodium bis (2-methoxyethoxy ·) aluminum dihydride, sodium cyanoborohydride and tributyltin hydride. For example, when lithium aluminum hydride is used, ether or hydrocarbons such as tetrahydrofuran or toluene or mixtures thereof are useful as solvents.

30 Når der bruges natriumborhydrid udføres reaktionen enten i et passende opløsningsmiddel, fx dimetylsulfoxyd, en opløsnings-middelblanding eller ved faseoverføringsteknik under anvendelse af fx toluen som organisk opløsningsmiddel.When sodium borohydride is used, the reaction is carried out either in a suitable solvent, for example dimethyl sulfoxide, a solvent mixture or by phase transfer technique using, for example, toluene as an organic solvent.

Når der bruges natrium-bis-(2-metoxyætoxy)-aluminiumhy-35 drid udføres reaktionen fortrinsvis i toluen skønt der kan bruges mange andre opløsningsmidler og opløsningsmiddelblandinger. Fx er hexametylenfosfortriamid egnet som opløsningsmiddel når der bruges natriumcyanborhydrid og fx toluen når 1 1When sodium bis (2-methoxyethoxy) aluminum hydride is used, the reaction is preferably carried out in toluene, although many other solvents and solvent mixtures can be used. For example, hexamethylene phosphorus triamide is suitable as a solvent when sodium cyanoborohydride is used and, for example, toluene when 1 1

DK 165785BDK 165785B

der bruges tributyltinhydrid.tributyltin hydride is used.

Metalhydridreduktionen udføres sædvanligvis ved en temperatur noget over stuetemperatur, fx ved ca. 50°C. Den katalytisk hydrogenering udføres ved hydrogenolyse i nærværel-5 se af fx en ædelmetalkatalysator. Blandt metalkatalysatorer kan nævnes palladium på kul og palladium på bariumsulfat og blandt andre katalysatorer fx Raney-nikkel. Hydrogeneringen udføres under enten sure, neutrale eller alkaliske betingelser. Som opløsningsmiddel bruges der fx en eller anden alkohol 10 såsom metanol eller ætanol eller en eller anden karboxylsyre, fx eddikesyre. Reaktionen udføres fortrinsvis ved stuetemperatur eller en smule derover. Reduktionen med et opløst metal udføres med zink/eddikesyre-behandling, der er bedst egnet til reduktion af trifenyljodid og -bromid (VIII, X = I eller 15 Br). Reaktionen udføres fortrinsvis ved en temperatur over stuetemperatur. Som et andet eksempel til reduktion med et opløst metal kan der nævnes et alkalimetal såsom litium opløst i flydende ammoniak. Blandt mellemprodukter ved reduktionen via mellemprodukter af Grignard-type kan nævnes Grignard-20 eller magniumkomplekset (VIII, X = Mghal) og litiumsaltet (VIII, X = Li). Grignard-komplekset fremstilles ud fra trife-nylhalogenidet VIII med magnium i et passende æter-opløsningsmiddel såsom tetrahydrofuran eller en opløsningsmiddelblanding indeholdende en eller anden æter. Reaktionen udføres fortrins-25 vis ved stuetemperatur. Litiumsaltet kan fremstilles enten direkte ud fra litiummetal eller ved hjælp af en bytningsreaktion med et passende litiumsalt, fx butyllitium. Som opløsningsmiddel bruges fx enten et kulbrinteopløsningsmiddel, fx hexan, eller et æteropløsningsmiddel såsom diætylæter eller 30 en blanding deraf.The metal hydride reduction is usually carried out at a temperature slightly above room temperature, e.g. 50 ° C. The catalytic hydrogenation is carried out by hydrogenolysis in the presence of, for example, a precious metal catalyst. Among metal catalysts are palladium on coal and palladium on barium sulfate and, among other catalysts, for example Raney nickel. The hydrogenation is carried out under either acidic, neutral or alkaline conditions. As the solvent, for example, some alcohol is used, such as methanol or ethanol or some carboxylic acid, for example acetic acid. The reaction is preferably carried out at room temperature or slightly above. The reduction with a dissolved metal is carried out with zinc / acetic acid treatment which is best suited for the reduction of triphenyl iodide and bromide (VIII, X = I or 15 Br). The reaction is preferably carried out at a temperature above room temperature. As another example for reduction with a dissolved metal, mention may be made of an alkali metal such as lithium dissolved in liquid ammonia. Among the intermediates in the reduction via Grignard-type intermediates may be mentioned the Grignard-20 or the magnesium complex (VIII, X = Mghal) and the lithium salt (VIII, X = Li). The Grignard complex is prepared from the triphenyl halide VIII with magnesium in a suitable ether solvent such as tetrahydrofuran or a solvent mixture containing some ether. The reaction is preferably carried out at room temperature. The lithium salt can be prepared either directly from lithium metal or by an exchange reaction with a suitable lithium salt, for example, butyllithium. As a solvent, for example, either a hydrocarbon solvent, eg hexane, or an ether solvent such as diethyl ether or a mixture thereof is used.

Det magniumkompleks eller litiumsalt der opstår som mellemprodukt nedbrydes, til tamoxifen I, fx ved hjælp af et opløsningsmiddel indeholdende en hydroxygruppe, fx vand. Afsvovlingen af en tioæter fremstillet ud fra halogenidet til 35 tamoxifen gennemføres på følgende måde: Først omsættes trife-nylhalogenidet VIII med en tioalkohol eller tiofenol, fortrinsvis i form af et natriumsalt deraf, til dannelse af en tioæter. Når fx natriumsaltet af ætylmerkaptan reagerer med tri-The magnesium complex or lithium salt which breaks down as an intermediate is decomposed into tamoxifen I, for example by means of a solvent containing a hydroxy group, for example water. The desulphurization of a thioether prepared from the halide to tamoxifen is carried out as follows: First, the trifanyl halide VIII is reacted with a thioalcohol or thiophenol, preferably in the form of a sodium salt thereof, to form a thioether. For example, when the sodium salt of ethyl mercaptan reacts with

DK 165785 BDK 165785 B

12 fenylhalogenidet VIII i et passende opløsningsmiddel, fx di-metylsulfoxyd, dannes den tilsvarende ætyltioæter VIII (X = sch2ch3).When the phenyl halide VIII in a suitable solvent, e.g., dimethylsulfoxide, is formed, the corresponding ethylthioether VIII (X = sch2ch3).

I den påfølgende reaktion reduceres tioæteren VIII 5 (X fx SCE^CH^) til tamoxifen. Reduktionen udføres med fx Raney-nikkel i ætanol.In the subsequent reaction, the thioether VIII 5 (X e.g. SCE ^ CH 2) is reduced to tamoxifen. The reduction is carried out with, for example, Raney nickel in ethanol.

Trifenylsulfonaterne IX reduceres til tamoxifen I med fx et metalhydrid-reduktionsmiddel eller ved afsvovling af en tioæter fremstillet ud fra et sulfonat. Metalhydridreduk-10 tionen og fremstillingen og afsvovlingen af tioæteren udføres på praktisk talt samme måde som nævnt ovenfor i forbindelse med reduktionen af trifenylhalogeniderne V.III.The triphenyl sulfonates IX are reduced to tamoxifen I with, for example, a metal hydride reducing agent or by desulfurization of a thioether prepared from a sulfonate. The metal hydride reduction and the preparation and desulfurization of the thioether are carried out in substantially the same manner as mentioned above in connection with the reduction of the triphenyl halides V.III.

Dehydratiseringen af trifenyldiol V til trifenylfuranet X kan udføres fx på følgende måde: Når man behandler trifenyl-15 diolen V med en sur katalysator under passende betingelser fraspaltes der vand og trifenylfuranet X dannes. Som eksempel på egnede sure katalysatorer kan nævnes saltsyre og svovlsyre og eksempler på egnede opløsningsmidler er alkoholiske sådanne. Når der bruges svovlsyre som sur katalysator og ætanol 20 som opløsningsmiddel udføres reaktionen fortrinsvis ved en smule over stuetemperatur. Ved syrning af reaktionsblandingen i forbindelse med fremstillingen af trifenyldiolen V med fx saltsyre kan trifenylfuranet X vindes uden nogen isolation af trifenyldiolen V.The dehydration of triphenyl diol V to the triphenylfuran X can be carried out, for example, as follows: When treating the triphenyl diol V with an acidic catalyst under appropriate conditions, water is decomposed and the triphenyl furan X is formed. Examples of suitable acidic catalysts include hydrochloric acid and sulfuric acid, and examples of suitable solvents are alcoholic ones. When sulfuric acid is used as acid catalyst and ethanol 20 as the solvent, the reaction is preferably carried out at slightly above room temperature. By acidifying the reaction mixture in connection with the preparation of the triphenyl diol V with, for example, hydrochloric acid, the triphenylfuran X can be recovered without any isolation of the triphenyl diol V.

25 Hvis trifenyldiolen V behandles med en sur katalysator under passende betingelser i et passende opløsningsmiddel vindes trifenylalkoholen VII ved dehydratisering. Under de samme betingelser åbnes tetrahydrofuranringen i trifenylfuranet X også og der dannes ligeledes trifenylalkoholen VII.If the triphenyl diol V is treated with an acidic catalyst under appropriate conditions in a suitable solvent, the triphenyl alcohol VII is obtained by dehydration. Under the same conditions, the tetrahydrofuran ring in the triphenylfuran X is also opened and the triphenyl alcohol VII is also formed.

30 Som sur katalysator kan der bl.a. bruges tørt hydrogenklorid eller koncentreret saltsyre og som opløsningsmiddel alkoholer som fx ætanol. Reaktionen udføres fortrinsvis ved blandingens kogepunkt eller ved lavere temperatur.As an acid catalyst, dry hydrogen chloride or concentrated hydrochloric acid is used and as a solvent alcohols such as ethanol. The reaction is preferably carried out at the boiling point of the mixture or at a lower temperature.

Når endvidere trifenylfuranet X behandles med en sur 35 katalysator under passende betingelser i en organisk syre, i dette tilfælde eddikesyre, åbnes tetrahydrofuranringen og trifenylacetatet VI dannes. Under de samme betingelser dannes ligeledes trifenylacetatet VI ud fra trifenyldiolen V. Som 1 3Furthermore, when the triphenylfuran X is treated with an acidic catalyst under appropriate conditions in an organic acid, in this case acetic acid, the tetrahydrofuran ring is opened and the triphenyl acetate VI is formed. Under the same conditions, the triphenyl acetate VI is also formed from the triphenyl diol V. As 1 3

DK 165785BDK 165785B

sur katalysator kan fx bruges hydrogenbromid. Reaktionen udføres fortrinsvis enten ved blandingens kogepunkt eller ved lavere temperatur.acid catalyst can be used, for example, hydrogen bromide. The reaction is preferably carried out either at the boiling point of the mixture or at a lower temperature.

Fremstilling af hydroxyhalogeniderne XI og hydroxysul-5 fonaterne XII ud fra trifenyldiolen V samt dehydratiseringen til trifenylhalogeniderne VIII og trifenylsulfonaterne udføres under anvendelse af tilsvarende reaktioner som beskrevet foran. Fremstilling og dehydratisering af hydroxysulfonaterne XII kan også udføres i ét kombineret reaktionstrin.Preparation of the hydroxy halides XI and hydroxy sulfonates XII from the triphenyl diol V as well as the dehydration to the triphenyl halides VIII and the triphenyl sulfonates are carried out using similar reactions as described above. Preparation and dehydration of the hydroxy sulfonates XII can also be carried out in one combined reaction step.

10 Fremstilling af trifenylhalogeniderne VIII ud fra tri fenyldiolen V eller trifenylfuranet X i ét reaktionstrin kan udføres fx ved følgende metoder. Når trifenyldiolen V omsættes med tionylklorid i et passende opløsningsmiddel, fx kloroform eller toluen, dannes trifenylkloridet VIII (X = Cl). Reaktio-15 nen udføres fortrinsvis som en totrinsreaktion. I første trin bruges der afkøling og i andet trin opvarmning. Når tilsvarende trifenylfuranet X omsættes med trifenylfosfindibromid i et passende opløsningsmiddel, fx acetonitril, dannes trifenyl-bromidet VIII (X = Br). Reaktionen udføres fortrinsvis ved 20 opvarmning.Preparation of the triphenyl halides VIII from the tri phenyl diol V or triphenylfuran X in one reaction step can be carried out, for example, by the following methods. When the triphenyl diol V is reacted with thionyl chloride in a suitable solvent, e.g., chloroform or toluene, the triphenyl chloride VIII (X = Cl) is formed. The reaction is preferably carried out as a two-step reaction. In the first step, cooling is used and in the second stage heating is used. When the corresponding triphenylfuran X is reacted with triphenylphosphine dibromide in a suitable solvent, for example acetonitrile, the triphenyl bromide VIII is formed (X = Br). The reaction is preferably carried out by heating.

Den i forbindelse med den foreliggende opfindelse beskrevne reaktionsfølge udføres fortrinsvis på en sådan måde at kun en del af mellemprodukterne renses. Hvis fx trifenyldiolen V renses ved omkrystallisation kan resten af reaktionsføl-25 gen gennemføres uden rensning af mellemprodukterne. Operationen kan også gøres på en sådan måde at man i stedet for trifenyldiolen V kun renser trifenylkloridet VIII (X = Cl) eller trifenylalkoholen VII. Om ønsket kan også adskillelse af iso-mererne udføres i samme sammenhæng. Faktisk udføres rensningen 30 og isomeradskillelsen fortrinsvis i en og samme sammenhæng.The reaction sequence described in connection with the present invention is preferably carried out in such a way that only part of the intermediates is purified. For example, if the triphenyl diol V is purified by recrystallization, the remainder of the reaction can be carried out without purification of the intermediates. The operation can also be done in such a way that instead of the triphenyl diol V, only the triphenyl chloride VIII (X = Cl) or triphenyl alcohol VII is purified. If desired, separation of the isomers can also be carried out in the same context. In fact, purification 30 and isomer separation are preferably performed in one and the same context.

(Z)-Isomeren kan isoleres fra blandingen af (Z)- og (E)-isomeren, både i trifenylacetatstadiet VI, trifenylalkohol-stadiet VII, trifenylhalogenidstadiet VIII og trifenylsulfonat-stadiet. Reaktionsfølgen kan også udføres på en sådan måde 35 at (Z)-isomeren ikke isoleres før tamoxifen-stadiet.The (Z) isomer can be isolated from the mixture of the (Z) and (E) isomer, both in triphenyl acetate stage VI, triphenyl alcohol stage VII, triphenyl halide stage VIII and triphenyl sulfonate stage. The reaction can also be carried out in such a way that the (Z) isomer is not isolated before the tamoxifen stage.

(Z)-Isomeren kan også isoleres lige så vel når isome-rerne er frie baser som når de er i saltform. Isolationen af (Z)-isomeren fra isomerblandingen udføres enten ved frak- 14The (Z) isomer can also be isolated as well when the isomers are free bases as when in salt form. The isolation of the (Z) isomer from the isomer mixture is carried out either by fraction 14

DK 165785BDK 165785B

tioneret krystallisation, fraktioneret opløsning, kromatografisk eller ved en kombination af disse metoder.ionized crystallization, fractional solution, chromatographically or by a combination of these methods.

Ved fremgangsmåden til fremstilling af tamoxifen i henhold til den foreliggende opfindelse fjernes den funktio-5 nelle gruppe ved enden af ætylgruppen i sidste trin. I princippet kan også acetoxytamoxifen VI og tamoxifenalkoholen vi I reduceres direkte til tamoxifen. I litteraturen er sådanne processer endog beskrevet, ved hvilke man ved reduktion af alkoholer, estere eller ætere vinder de tilsvarende hydrider 10 (se fx Compendium of Organic Synthetic Methods, bind 1-4,In the process of preparing tamoxifen according to the present invention, the functional group is removed at the end of the ethyl group in the last step. In principle, acetoxytamoxifen VI and tamoxifen alcohol V I can also be reduced directly to tamoxifen. In the literature, such processes are even described in which, by reducing alcohols, esters or ethers, the corresponding hydrides 10 are obtained (see, e.g., Compendium of Organic Synthetic Methods, Vols 1-4,

sektionerne 153, 158 og 159). De pågældende reduktioner lykkes almindeligvis dårligt i normale tilfælde og behøver ofte meget kraftige betingelser. Osections 153, 158 and 159). The reductions in question generally succeed poorly in normal cases and often require very severe conditions. ISLAND

Gruppen -CH^OH eller -Cf^O-C-CH^ kan lettere reduceres 15 til CH^-gruppen via det tilsvarende halogenid eller den tilsvarende sulfonsyreester, men andre estere såsom tiokarbamater (se Chem. Commun. 1979, 1175) kan også bruges.The group -CH₂OH or -Cf₂O-C-CH₂ can be more easily reduced to the CH₂ group via the corresponding halide or sulfonic acid ester, but other esters such as thiocarbamates (see Chem. Commun. 1979, 1175) may also be used.

Simple halogenider og sulfonater kan let fremstilles ud fra de tilsvarende alkoholer i høje udbytter. Desuden kan 20 simple halogenider og sulfonater let reduceres i høje udbytter til de tilsvarende hydrider ved forskellige processer (se fx Compendium of Organic Synthetic Methods, bind 1-4, sektion 160, og Synthesis 1980, 425-452).Simple halides and sulfonates can be readily prepared from the corresponding alcohols in high yields. In addition, 20 simple halides and sulfonates can be readily reduced in high yields to the corresponding hydrides by various processes (see, e.g., Compendium of Organic Synthetic Methods, Vol. 1-4, Section 160, and Synthesis 1980, 425-452).

Det virkelig opfinderiske 25 ligger i den ekstreme lethed ved hvilken frem for alt trifenylhalogeniderne VIII og blandt dem især trifenylkloridet (X = Cl) kan fremstilles i to meget simple og teknisk let gennemførlige reaktioner i gode udbytter. Det tredje og sidste trin, i hvilket trifenylhalogenidet VIII eller trifenylsulfo-30 natet IX reduceres til tamoxifen er ligeledes opfinderisk fordi det ikke kunne forudses at en forbindelse med en så kompliceret struktur som forbindelserne VIII og IX, dys. indeholdende en dobbeltbinding, så let kunne reduceres til tamoxifen og det i praktisk talt kvantitativt udbytte.The truly inventive 25 lies in the extreme ease with which, above all, the triphenyl halides VIII and, in particular, the triphenyl chloride (X = Cl) can be prepared in two very simple and technically feasible reactions in good yields. The third and final step in which the triphenyl halide VIII or triphenyl sulfonate IX is reduced to tamoxifen is also inventive because it could not be anticipated that a compound having such a complex structure as compounds VIII and IX, dys. containing a double bond so as to be readily reduced to tamoxifen and in practically quantitative yield.

35 1535 15

DK 165785BDK 165785B

Eksempel 1 1,2-Difenyl-l-{4-[2-(N,N-dimetylamino)-ætoxy]-fenyl}-butan- 1,4-diol (trifenyldiol V; RR, SS? RS, SR)_ 5 Til en reaktionskolbe indeholdende 20 g litiumalumini- umhydrid opløst og dispergeret i 500 ml tørt tetrahydrofuran tilføres der under omrøring 132 g kanelaldehyd opløst i 750 ml tørt tetrahydrofuran. Temperaturen holdes mellem 25 og 35°C under tilsætningen. Når hele mængden af kanelaldehyd 10 er tilsat omrøres blandingen i yderligere 30 minutter ved stuetemperatur. Derpå tilsættes der under omrøring 269 g 4-(2-(N,N-dimetylamino)-ætoxy]-benzofenon (IV) opløst i 1000 ml tørt tetrahydrofuran. Temperaturen holdes på 35-45°C under tilsætningen. Når alt benzofenonet er tilsat omrøres blandin-15 gen i yderligere 2 timer ved 45°C. Herefter sættes der under omrøring til reaktionsblandingen først 20 ml vand, derpå 20 g 15%s natriumhydroxydopløsning og til sidst 60 ml vand. Det udfældede litium- og aluminiumhydroxyd fjernes ved filtrering. Derefter afdestilleres opløsningsmidlet og remanensen omkry-20 stalliseres fra toluen. Udbyttet af ren isomerblanding er 243-324 g (60-80%) og smeltepunktet 127-151°C. Isomerblandin-gen indeholder af opløselighedsgrunde ca. 60% (RR, SS)-enan-tiomerpar skønt der dannes lige meget af begge par ved reaktionen. Ved omkrystallisation af isomerblandingen fra acetone 25 vindes (RR, SS)-enantiomerparret med smp. 165-167°C (fra toluen). Ved inddampning af acetone-moderluden og ved omkrystallisation to gange af inddampningsresten fra acetone vindes (RS, SR)-enantiomerparret med smp. 139-141 C (fra toluen). 1 2 3 4 5 6 4-Acetoxy-l,2-difeny1-1-^4 -[2-(N,N-dimetylamino)-ætoxy]-fenyl} - 2 1-buten (trifenylacetatet VI; Z og Z,E)_ 3 405 g af trifenyldiolen V, enten rent enantiomerpar 4 eller blanding deraf, opløses i 1500 ml varmt eddikesyreanhy- 5Example 1 1,2-Diphenyl-1- {4- [2- (N, N-dimethylamino) -ethoxy] -phenyl} -butane-1,4-diol (triphenyldiol V; RR, SS? RS, SR) To a reaction flask containing 20 g of lithium aluminum hydride dissolved and dispersed in 500 ml of dry tetrahydrofuran, add, with stirring, 132 g of cinnamal aldehyde dissolved in 750 ml of dry tetrahydrofuran. The temperature is maintained between 25 and 35 ° C during the addition. When the entire amount of cinnamon aldehyde 10 is added, the mixture is stirred for an additional 30 minutes at room temperature. Then, with stirring, 269 g of 4- (2- (N, N-dimethylamino) -ethoxy) -benzophenone (IV) dissolved in 1000 ml of dry tetrahydrofuran are added and the temperature is maintained at 35-45 ° C during the addition. The mixture is stirred for an additional 2 hours at 45 DEG C. Then, with stirring, the reaction mixture is first added with 20 ml of water, then 20 g of 15% sodium hydroxide solution and finally 60 ml of water. The precipitated lithium and aluminum hydroxide are removed by filtration. The solvent is then distilled off and the residue recrystallized from toluene The yield of pure isomer mixture is 243-324 g (60-80%) and the melting point 127-151 ° C. The isomer mixture contains about 60% for solubility reasons (RR, SS) -enan-thiomer pairs, although both pairs are formed in the reaction. Upon recrystallization of the isomer mixture from acetone 25, the (RR, SS) -enantiomer pair is obtained, mp 165-167 ° C (from toluene). by recrystallization twice of the residue from acetone, the (RS, SR) enantiomer pair is obtained with m.p. 139-141 ° C (from toluene). 1 2 3 4 5 6 4-Acetoxy-1,2-diphenyl-1- [4- [2- (N, N-dimethylamino) -ethoxy] -phenyl} -2-butene (triphenylacetate VI; Z and Z, E) 3 405 g of triphenyl diol V, either pure enantiomer pair 4 or mixture thereof, are dissolved in 1500 ml of hot acetic anhydride.

drid. Blandingen omrøres i 1 time ved en temperatur på 90°Canhydride. The mixture is stirred for 1 hour at a temperature of 90 ° C

6 hvorved den primære hydroxygruppe acetyleres (som mellemprodukt dannes hydroxyacetatet XIII; smeltepunktet af (RR,SS)-enantiomerparret er 97-99°C). Derpå tilsættes der under omrøring 318 g acetylklorid opløst i 500 ml eddikesyreanhydrid 166 whereby the primary hydroxy group is acetylated (as intermediate, the hydroxy acetate XIII is formed; the melting point of the (RR, SS) enantiomer pair is 97-99 ° C). Then, with stirring, 318 g of acetyl chloride dissolved in 500 ml of acetic anhydride 16 are added.

DK 165785BDK 165785B

hvorpå reaktionsblandingen holdes i 3 timer på 90°C. Til sidst afdampes opløsningsmidlet til frembringelse af hydroklo-ridsaltet af (Z,E)-trifenylacetatet VI i kvantitativt udbytte.whereupon the reaction mixture is kept at 90 ° C for 3 hours. Finally, the solvent is evaporated to give the hydrochloride salt of (Z, E) triphenyl acetate VI in quantitative yield.

I remanensen,som har smp. 114-122°C, er 2/3 den ønskede (Z)-5 isomer og 1/3 (E)-isomeren. (Z)-Isomerens smp. som fri base er 67-69°C.In the residue, which has m.p. 114-122 ° C, 2/3 is the desired (Z) -5 isomer and 1/3 (E) isomer. (Z) -Isomer m.p. as free base is 67-69 ° C.

1,2-Difenyl-l- {4-[2-(Ν,Ν-dimetylamino)-ætoxy]-fenylJ-l-buten- 4-ol (trifenylalkoholen VII; Z og Z,E)_ 10 Remanensen indeholdende hydrokloridet af (Z,E)-trifenyl acetatet VI (Z:E = 2:1) vundet i foregående trin opløses i 2000 ml ætanol. Derefter gøres opløsningen neutral med 20%s natriumhydro.xydopløsning. Der tilsættes 300 ml eller mere 20%s natriumhydroxydopløsning og 200 ml vand hvorpå blandingen 15 tilbagesvales i 1 time. Reaktionsblandingen neutraliseres med 2M saltsyre. Opløsningsmidlet afdampes og til remanensen sættes der vand. Derefter ekstraheres produktet med en blanding af toluen og ætylacetat 8.2. Efter vask med vand afdampes opløsningsmidlerne til frembringelse af (Z,E)-trifenylal-20 koholen VII (Z:E = 2:1) i kvantitativt udbytte. Remanensens smp. er 93-100°C. Den ønskede (Z)-isomer isoleres fx som følger: Metode a. Den ovenfor vundne (Z,E)-trifenylalkoho-l VII (Z:E = 2:1) omkrystalliseres fra toluen til frembringelse af 157 g (Z)-trifenylalkohol VII, hvilket svarer til 41% be-25 regnet ud fra den anvendte mængde af trifenyldiolen V. Smp. af (Z)-trifenylalkoholen er 110-112°C. Derefter omdannes den i toluen-moderluden tilbageværende isomerblanding til hydro-kloridsaltet enten ved at der føres hydrogenkloridgas ind i opløsningen eller ved at man tilsætter en blanding af æta-30 nol og koncentreret saltsyre. Derefter afdampes opløsningsmidlet. Remanensen opløses i kogende acetone hvorved (Z)-isomeren opløser sig fuldstændigt og hovedparten af (E)-isomeren forbliver uopløst. Den afkølede opløsning filtreres til fjernelse af udfældet (E)-trifenylalkohol VII. Efter afdmapning af ace-35 tonen opløses remanensen i kogende ætanol. Ved afkøling af opløsningen udkrystalliseres yderligere 47 g (11%) (Z)-trife-nylalkohol VII i form af hydrokloridsaltet deraf. Det samlede udbytte af trifenylalkoholen VII er således 52% ved beregning1,2-Diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] -phenyl] -1-buten-4-ol (triphenyl alcohol VII; Z and Z, E) - The residue containing the hydrochloride of The (Z, E) triphenyl acetate VI (Z: E = 2: 1) obtained in the previous step is dissolved in 2000 ml of ethanol. The solution is then neutralized with 20% sodium hydroxide solution. Add 300 ml or more of 20% sodium hydroxide solution and 200 ml of water to reflux for 1 hour. The reaction mixture is neutralized with 2M hydrochloric acid. The solvent is evaporated and water is added to the residue. The product is then extracted with a mixture of toluene and ethyl acetate 8.2. After washing with water, the solvents are evaporated to give the (Z, E) triphenylalcohol VII (Z: E = 2: 1) in quantitative yield. M.p. is 93-100 ° C. The desired (Z) isomer is isolated, for example, as follows: Method a. The above-obtained (Z, E) triphenyl alcohol-VII (Z: E = 2: 1) is recrystallized from toluene to give 157 g (Z) triphenyl alcohol. VII, which corresponds to 41% calculated from the amount of triphenyl diol used. of the (Z) triphenyl alcohol is 110-112 ° C. Then, the isomer mixture remaining in the toluene mother liquor is converted to the hydrochloride salt either by introducing hydrogen chloride gas into the solution or by adding a mixture of ethanol and concentrated hydrochloric acid. The solvent is then evaporated. The residue is dissolved in boiling acetone whereby the (Z) isomer dissolves completely and the majority of the (E) isomer remains undissolved. The cooled solution is filtered to remove precipitated (E) triphenyl alcohol VII. After evaporation of the acetone, the residue is dissolved in boiling ethanol. Upon cooling the solution, an additional 47 g (11%) of (Z) -trifertyl alcohol VII is crystallized in the form of its hydrochloride salt. Thus, the total yield of triphenyl alcohol VII is 52% by calculation

DK 165785 BDK 165785 B

17 ud fra mængden af anvendt trifenyldiol V. Smeltepunktet af (Z)-trifenylalkoholen VII's hydroklorid er 166-168°C (fra acetone). Om ønsket kan (Z)-isomeren frigøres fra sit hydro-kloridsalt på følgende måde.17 from the amount of triphenyl diol V. The melting point of the (Z) triphenyl alcohol VII hydrochloride is 166-168 ° C (from acetone). If desired, the (Z) isomer can be released from its hydrochloride salt as follows.

5 Først opløses hydrokloridsaltet i varmt vand hvorefter der tilsættes 10%s natriumkarbonatopløsning. Derpå ekstraheres den frigivne (Z)-isomer fra den afkølede opløsning i en blanding af toluen og ætylacetat. Til sidst vaskes der med vand og inddampes. (Z)-Isomeren vindes som fri base uden ekstrak-10 tionstab.5 First, the hydrochloride salt is dissolved in hot water and then 10% s sodium carbonate solution is added. Then, the released (Z) isomer is extracted from the cooled solution in a mixture of toluene and ethyl acetate. Finally, wash with water and evaporate. The (Z) isomer is obtained as a free base without extraction loss.

Metode b. (Z,E)-Trifenylalkoholresten (VII, Z:E = 2:1) vundet ovenfor opløses i acetone hvorefter den omdannes til hydrokloridsaltet deraf ved at der føres hydrogenklorid ind i opløsningen. Derpå behandles hydrokloridisomerblandingen 15 med acetone og omkrystalliseres som beskrevet under metode a. Udbyttet af hydroklorid af (Z)-trifenylalkoholen VII er 195 g hvilket svarer til 41% regnet ud fra den anvendte mængde trifenyldiol V.Method b. (Z, E) -The triphenyl alcohol residue (VII, Z: E = 2: 1) obtained above is dissolved in acetone and then converted to the hydrochloride salt thereof by introducing hydrogen chloride into the solution. Then, the hydrochloride isomer mixture 15 is treated with acetone and recrystallized as described under Method a. The yield of hydrochloride of (Z) -riphenyl alcohol VII is 195 g, which is 41%, based on the amount of triphenyldiol V used.

Metode c. Den som beskrevet ovenfor vundne (Z,E)-trife-20 nylalkoholrest (VII, Z:E = 2:1) opløses i ætanol hvorpå isomer-blandingen omdannes til hydrokloridsaltet deraf ved at der føres hydrogenklorid ind i opløsningen. Når den opvarmede opløsning får lov til at afkøle danner der sig et bundfald som omkrystalliseres endnu en gang fra ætanol. På denne måde 25 vindes der 123 g hydrokloridsalt af (Z)-trifenylalkoholen VII, hvilket svarer til 29% regnet ud fra den anvendte mængde trifenyldiol V.Method c. The (Z, E) -trifertyl alcohol residue (VII, Z: E = 2: 1) obtained as described above is dissolved in ethanol and the isomer mixture is converted to the hydrochloride salt thereof by introducing hydrogen chloride into the solution. When the heated solution is allowed to cool, a precipitate forms, which is recrystallized again from ethanol. In this way, 123 g of hydrochloride salt of (Z) -riphenyl alcohol VII is obtained, which corresponds to 29% based on the amount of triphenyldiol V used.

Metode d. (Z)-Tamoxifen isoleres let fra (Z)- og (E)-isomerblandingen fx ved søjle- eller lagkromatografering for-30 di (Z)-isomeren bevæger sig bemærkelsesværdigt hurtigere med mange opløsningsmidler end (E)-isomeren. Ved isolering ved søjle- eller lagkromatografi bruges der som mobilt opløsningsmiddel fx enten toluen-Et^N 90:10 (R^/Z 0,20; R^/E 0,05) eller CHCl^/MeOH/koncentreret NH^ 90:95:0,5 (R^/Z 0,49; R^/E 0,33).Method d. (Z) Tamoxifen is readily isolated from the (Z) and (E) isomer mixture, for example, by column or layer chromatography for the (Z) isomer moving remarkably faster with many solvents than the (E) isomer. In isolation by column or layer chromatography, as a mobile solvent, for example, either toluene-Et 1 N 90:10 (R 2 / Z 0.20; R 2 / E 0.05) or CHCl 3 / MeOH / concentrated NH 3 90 is used: 95: 0.5 (R f / Z 0.49; R f / E 0.33).

35 1835 18

DK 165785BDK 165785B

Eksempel 2 4-Klor-l,2-difenyl-l-{4-[2-(Ν,Ν-dimetylamino)-ætoxy]-f enylj - 1-buten (trifenylkloridet VIII; X = Cl; (Z))__ 387 g (Z)-trifenylalkohol VII enten som fri base, hydro-^ kloridsalt eller en blanding deraf opløses i 2400 ml kloroform. Der tilsættes 238 g tionylklorid og derefter tilbagesvales blandingen i 3 timer. Efter afdampning af opløsningsmidlet tilsættes der 10%s natriumkarbonatopløsning hvorpå produktet ekstraheres med toluen. Efter vask med vand afdestilleres ^ opløsningsmidlet til frembringelse af (Z)-trifenylkloridet VIII (X = Cl) i kvantitativt udbytte. Smeltepunktet af dette (Z)-trifenylklorid VIII som fri base efter omkrystallisation fra acetone er 108-110°C og smeltepunktet af hydrokloridsaltet 194-196°C efter omkrystallisation fra acetone.Example 2 4-Chloro-1,2-diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] -phenyl] -1-butene (triphenyl chloride VIII; X = Cl; (Z)) 387 g of (Z) triphenyl alcohol VII either as free base, hydrochloride salt or a mixture thereof is dissolved in 2400 ml of chloroform. 238 g of thionyl chloride are added and then the mixture is refluxed for 3 hours. After evaporation of the solvent, 10% of sodium carbonate solution is added and the product is extracted with toluene. After washing with water, the solvent is distilled off to give the (Z) triphenyl chloride VIII (X = Cl) in quantitative yield. The melting point of this (Z) triphenyl chloride VIII as free base after recrystallization from acetone is 108-110 ° C and the melting point of the hydrochloride salt 194-196 ° C after recrystallization from acetone.

1515

Tamoxifen (Z) (I)Tamoxifen (Z) (I)

Til en reaktionskolbe indeholdende 76 g litiumaluminium-hydrid opløst eller dispergeret i 1000 ml tørt tetrahydrofuran sættes den i foregående afsnit vundne (Z)-trifenylkloridrema-2Q nens (VIII, X = Cl) i 1500 ml tørt tetrahydrofuran hvorpå blandingen tilbagesvales i 4-5 timer. Overskydende reagens sønderdeles ved tilsætning af ætylacetat. Derpå tilsættes der under omrøring først 76 ml vand og derpå 76 g 15%s natriumhydroxyd og til sidst 228 ml vand. Det udfældede litium- og aluminium-hydroxyd fjernes ved filtrering hvorpå opløsningsmidlet afdam- pes. Remanensen opløses i toluen. Efter vask med vand og tørring over natriumsulfat afdestilleres toluenet til frembringelse af (Z)-tamoxifen I i kvantitativt udbytte. Derefter omdannes (Z)-tamoxifenet til citratsaltet på konventionel måde med ^ citronsyre i acetone. Det på denne måde vundne (Z)-tamoxifen-citronsyresalt smelter ved ca. 142°C og udbyttet er 507-535 g, hvilket svarer til 90-95% beregnet ud fra den anvendte mængde (Z)-trifenylalkohol VII.To a reaction flask containing 76 g of lithium aluminum hydride dissolved or dispersed in 1000 ml of dry tetrahydrofuran is added the (Z) triphenylchloride mixture (VIII, X = Cl) obtained in the previous section in 1500 ml of dry tetrahydrofuran and refluxed for 4-5 hours. hours. Excess reagent is decomposed by the addition of ethyl acetate. Then, with stirring, first 76 ml of water and then 76 g of 15% sodium hydroxide and finally 228 ml of water are added. The precipitated lithium and aluminum hydroxide are removed by filtration and the solvent is evaporated. The residue is dissolved in toluene. After washing with water and drying over sodium sulfate, the toluene is distilled off to give (Z) tamoxifen I in quantitative yield. Then, the (Z) tamoxifen is converted to the citrate salt in a conventional manner with ^ citric acid in acetone. The thus obtained (Z) -amoxifene citric acid salt melts at ca. 142 DEG C. and the yield is 507-535 g, which corresponds to 90-95% calculated from the amount of (Z) triphenyl alcohol VII used.

Trifenylkloridet (Ζ,Ε) (VIII, X = Cl) (Z,E)-Trifenylkloridet VIII (X = Cl; Z:E = 2:1) fremstilles ud fra toluen-ætylacetatremanensen fra (Z,E)-trifenyl- 35 19The triphenyl chloride (Ζ, Ε) (VIII, X = Cl) (Z, E) -The triphenyl chloride VIII (X = Cl; Z: E = 2: 1) is prepared from the toluene-ethyl acetate residue from (Z, E) 19

DK 165785BDK 165785B

alkoholen VII (Z:E = 2:1) på samme måde som den rene (Z)-iso-mer som beskrevet foran. Udbyttet efter afdampning af toluen er kvantitativt.the alcohol VII (Z: E = 2: 1) in the same manner as the pure (Z) isomer as described above. The yield after evaporation of toluene is quantitative.

Tamoxifen (Ζ,Ε) (I) 5 Toluenremanensen fra (Z,E)-trifenylkloridet VIII (X =Tamoxifen (Ζ, Ε) (I) The toluene residue from the (Z, E) triphenyl chloride VIII (X =

Cl; Z:E = 2:1) reduceres til (Z,E)-tamoxifen I (Z:E = 2:1) på samme måde som den rene (Z)-isomer beskrevet ovenfor. (Z)-Isomeren isoleres fra isomerblandingen ved kendte metoder og omdannes til citratsaltet som beskrevet ovenfor. Smeltepunk-10 tet af det på denne måde vundne (Z)-tamoxifen-citronsalt er ca. 142°C og udbyttet 225-253 g, hvilket svarer til 40-45% regnet ud fra den anvendte mængde trifenyldiol V.Cl; Z: E = 2: 1) is reduced to (Z, E) tamoxifen I (Z: E = 2: 1) in the same manner as the pure (Z) isomer described above. The (Z) isomer is isolated from the isomer mixture by known methods and converted to the citrate salt as described above. The melting point of the thus obtained (Z) -amoxifene lemon salt is approx. 142 ° C and the yield 225-253 g, which corresponds to 40-45% based on the amount of triphenyl diol V used.

Eksempel 3 15 4-Tosyloxy-l,2-difenyl-1-{4-[2-(Ν,Ν-dimetylamino)-ætoxyJ-fe-nylj-l-buten (Z og Z,E; trifenyltosylatet IX, R = 4-tolyl) 387 g (Z)-trifenylalkohol VII enten som fri base, som hydrokloridsalt eller som en blanding deraf opløses i 1000 2Q ml tørt pyridin. Under omrøring af reaktionsblandingen tilsættes der 572 g 4-toluensulfonsyreklorid opløst i 1000 ml tørt pyridin. Temperaturen holdes på 0°C under tilsætningen. Herefter omrøres rekationsblandingen i 4 timer ved 0°C. så tilsættes der under omrøring og idet temperaturen holdes på 0-2^ 10°C først 200 ml koldt vand og derpå kold 10%s saltsyre ind til reaktionsblandingen er sur. Det udfældede hydroklorid af (Z)-trifenyltosylat IX (R = 4-tolyl) opsamles ved filtrering, vaskes med vand og tørres. Bundfaldets smp. er 122-124°C og udbyttet kvantitativt. Smeltepunktet af det tilsvarende ^ (Z,E)-trifenyltosylat IX (Z:E = 2:1; R = 4-tolyl) er 80-105°C.Example 3 4-Tosyloxy-1,2-diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] -phenyl] -1-butene (Z and Z, E; the triphenyl tosylate IX, R = 4-tolyl) 387 g (Z) triphenyl alcohol VII either as a free base, as a hydrochloride salt or as a mixture thereof is dissolved in 1000 2Q ml of dry pyridine. While stirring the reaction mixture, 572 g of 4-toluenesulfonic acid chloride dissolved in 1000 ml of dry pyridine are added. The temperature is kept at 0 ° C during the addition. The reaction mixture is then stirred for 4 hours at 0 ° C. then with stirring and with maintaining the temperature of 0-2 ° 10 ° C, add 200 ml of cold water first and then cold 10% hydrochloric acid until the reaction mixture is acidic. The precipitated hydrochloride of (Z) triphenyl tosylate IX (R = 4-tolyl) is collected by filtration, washed with water and dried. The precipitate m.p. is 122-124 ° C and the yield quantitative. The melting point of the corresponding β (Z, E) triphenyl tosylate IX (Z: E = 2: 1; R = 4-tolyl) is 80-105 ° C.

Smeltepunktet af (Z)-isomeren frigivet ved behandling med toluen/base og omkrystalliseret fra petroleumsæter er 85-87°C. 1The melting point of the (Z) isomer released by treatment with toluene / base and recrystallized from petroleum ether is 85-87 ° C. 1

Tamoxifen (Z) (I)Tamoxifen (Z) (I)

Det ovenfor vundne hydroklorid af (Z)-trifenyitosylat IX (R = 4-tolyl) tritureres med 10%s natriumkarbonatopløsning 20The hydrochloride obtained above (Z) triphenyltosylate IX (R = 4-tolyl) is triturated with 10% sodium carbonate solution 20

DK 165785BDK 165785B

hvorpå det ekstraheres som fri base med toluen. Efter vask med vand afdestilleres toluenet for at tørre opløsningen indtil dens rumfang er 2000-2500 ml. Den vundne toluenopløsning sættes til 720 ml 70%s natrium-bis-(2-metoxyætoxy)-aluminium-hydrid-toluen-opløsning idet temperaturen holdes på 75°C un-5 der tilsætningen. Herefter fortsættes omrøringen ved samme temperatur i 3 timer. Overskydende reagens nedbrydes med ætylacetat hvorpå reaktionsopløsningen vaskes to gange med vand. Efter tørring over natriumsulfat afdampes opløsningsmidlet til frembringelse af (Z)-tamoxifen I i kvantitativt udbytte.whereupon it is extracted as free base with toluene. After washing with water, the toluene is distilled off to dry the solution until its volume is 2000-2500 ml. The toluene solution obtained is added to 720 ml of 70% sodium bis (2-methoxyethoxy) aluminum hydride-toluene solution while maintaining the temperature at 75 ° C during the addition. Thereafter, stirring is continued at the same temperature for 3 hours. Excess reagent is digested with ethyl acetate and then the reaction solution is washed twice with water. After drying over sodium sulfate, the solvent is evaporated to give (Z) tamoxifen I in quantitative yield.

10 Citratsaltet fremstilles som beskrevet ovenfor. Smeltepunktet af det vundne (Z)-tamoxifen-citronsyresalt er ca, 142°C og udbyttet 479-507 g, hvilket svarer til 85-90% regnet ud fra den anvendte mængde (Z)-trifenylalkohol V.The citrate salt is prepared as described above. The melting point of the (Z) -tamoxifen-citric acid salt obtained is about, 142 ° C and the yield is 479-507 g, which corresponds to 85-90% based on the amount of (Z)-triphenylalcohol V used.

15 Eksempel 4 2,3-Difenyl-2-£4-[2-(N,N-dimetylamino)-ætoxy]-fenylj -tetra- hydrofuran (trifenylfuran X; RR,SS; RS,SR)_ 405 g trifenyldiol V, enten et rent enantiomerpar eller 2Q en blanding deraf, opløses i en opløsning indeholdende 4000 ml ætanol, 150 ml koncentreret svovlsyre og 750 ml vand. Reaktionsblandingen omrøres i 3 timer ved en temperatur på 45°C. Opløsningen gøres neutral med 2M natriumhydroxyd hvorpå æta-nolen afdampes. Der sættes vand til remanensen og produktet ekstraheres med toluen. Efter tørring over natriumsulfat afdam-25 pes toluenet til frembringelse af trifenylfuranet X i kvantitativt udbytte, hvori (RR,SS)-enantiomerparret er bemærkelsesværdigt beriget på bekostning af (RS, SR)-parret. Smeltepunkt-tet af (RR,SS)-trifenylfuranet X er 83-85°C efter omkrystallisation fra ætanol.Example 4 2,3-Diphenyl-2- [4- [2- (N, N-dimethylamino) -ethoxy] -phenyl] -tetrahydrofuran (triphenylfuran X; RR, SS; RS, SR) - 405 g of triphenyldiol V , either a pure enantiomer pair or a mixture thereof, is dissolved in a solution containing 4000 ml of ethanol, 150 ml of concentrated sulfuric acid and 750 ml of water. The reaction mixture is stirred for 3 hours at a temperature of 45 ° C. The solution is neutralized with 2M sodium hydroxide and the ethanol is evaporated. Water is added to the residue and the product is extracted with toluene. After drying over sodium sulfate, the toluene is evaporated to give the triphenylfuran X in quantitative yield, wherein the (RR, SS) enantiomer pair is remarkably enriched at the expense of the (RS, SR) pair. The melting point of the (RR, SS) triphenylfuran X is 83-85 ° C after recrystallization from ethanol.

3030

Trifenylalkohol VII (Z,E) 387 g trifenylfuran X eller 405 g trifenyldiol V, enten som et rent enantiomerpar eller en blanding deraf, opløses i 2500 ml tør ætanol som indeholder overskud af hydrogenklorid-gas. Blandingen tilbagesvales i· 4 timer hvorpå opløsningsmidlet afdampes. Udbyttet af hydrokloridsaltet af trifenylalkoholenTriphenyl Alcohol VII (Z, E) Dissolve 387 g of triphenylfuran X or 405 g of triphenyl diol V, either as a pure enantiomer pair or a mixture thereof, in 2500 ml of dry ethanol containing excess hydrogen chloride gas. The mixture is refluxed for 4 hours and the solvent is evaporated. The yield of the hydrochloride salt of the triphenyl alcohol

DK 165785 BDK 165785 B

21 VII (Z:E = 2:1) er kvantitativt, men den indeholder som urenhed ca. 5% 2,3-difenyl-2-[4-(Ν,Ν-dimetylamino)-ætoxy]-fenyl-tetrahydrofuran. Isolationen af (Z)-isomeren udføres som i eksempel 1.21 VII (Z: E = 2: 1) is quantitative, but it contains as impurity approx. 5% 2,3-diphenyl-2- [4- (Ν, Ν-dimethylamino) -ethoxy] -phenyl-tetrahydrofuran. The isolation of the (Z) isomer is carried out as in Example 1.

55

Eksempel 5 4-Brom-l,2-difenyl-l-{4-[2-(Ν,Ν-dimetylamino)-ætoxy]-fenyl} - 1-buten (Z) (trifenylbromidet VIII, X = Br)_ 387 g (Z)-trifenylalkohol VII opløses i 3000 ml tør acetonitril. Under omrøring sættes der til blandingen først 395 g trifenylfosfin og derpå i små portioner 498 g kulstof-tetrabromid. Reaktionsbalndingen omrøres ved stuetemperatur i 2 timer. Opløsningen afkøles hvorved det ønskede produkt j udkrystalliserer og opsamles ved filtrering. Udbyttet er 306 g (68%) og smeltepunktet 114-116°C (fra metanol). Mere rent produkt kan om ønsket vindes fra moderluden.Example 5 4-Bromo-1,2-diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] -phenyl} -1-butene (Z) (the triphenyl bromide VIII, X = Br) - 387 g (Z) -riphenyl alcohol VII is dissolved in 3000 ml of dry acetonitrile. With stirring, 395 g of triphenylphosphine are added to the mixture first and then in small portions 498 g of carbon tetrabromide. The reaction mixture is stirred at room temperature for 2 hours. The solution is cooled to crystallize the desired product and collected by filtration. The yield is 306 g (68%) and the melting point 114-116 ° C (from methanol). More pure product can be obtained from the mother liquor if desired.

Tamoxifen (Z) (1) 2Q 306 g (Z)-trifenylbromid VIII (X = Br) og 51 g hexade- cyltributylfosfoniumbromid suspenderes i 340 ml toluen. Derefter tilsættes der 103 g natriumborhydrid opløst i 270 ml vand. Blandingen omrøres i 24 timer ved en temperatur på 50°C. Der tilsættes vand og derefter ekstraheres produktet med toluen. Toluenopløsningen tørres og opløsningsmidlet afdampes.Tamoxifen (Z) (1) 2Q 306 g (Z) triphenyl bromide VIII (X = Br) and 51 g hexadecyltributylphosphonium bromide are suspended in 340 ml of toluene. Then 103 g of sodium borohydride dissolved in 270 ml of water are added. The mixture is stirred for 24 hours at a temperature of 50 ° C. Water is added and then the product is extracted with toluene. The toluene solution is dried and the solvent is evaporated.

2 52 5

Hovedparten af remanensen består af borkomplekset af det ønskede produkt, men indeholder også noget kompleksfrit produkt. Remanensen opløses i 1700 ml absolut metanol og der tilsættes 340 ml koncentreret saltsyre. Blandingen omrøres i 2 timer 2q ved 50°C hvorved borkomplekset sønderdeles. Opløsningsmidlet afdestilleres hvorefter produktet suspenderes i toluen. Så tilsættes der 2M natriumhydroxydopløsning for at frigøre produktet fra HCl-saltet deraf. Det vandige lag kasseres og toluenlaget vaskes med vand. Opløsningsmidlet afdampes derefter ^ til frembringelse af (Z)-tamoxifen I i næsten kvantitativt udbytte. Citratsaltet fremstilles som beskrevet ovenfor.Most of the residue consists of the boron complex of the desired product, but also contains some complex-free product. The residue is dissolved in 1700 ml of absolute methanol and 340 ml of concentrated hydrochloric acid is added. The mixture is stirred for 2 hours at 2 ° C at 50 ° C, thereby decomposing the boron complex. The solvent is distilled off and the product is suspended in toluene. Then 2M sodium hydroxide solution is added to release the product from the HCl salt thereof. The aqueous layer is discarded and the toluene layer is washed with water. The solvent is then evaporated to give (Z) tamoxifen I in almost quantitative yield. The citrate salt is prepared as described above.

DK 165785 BDK 165785 B

2222

Eksempel 6 Tamoxifen (Z) (I) 40,6 g (Z)-trifenylklorid VIII (X = Cl) opløses i 1000 ml ætanol og derefter tilsættes der 41,4 g tørt kaliumkarbonat 5 og 12 g 5%s palladium/kul. Reaktionsblandingen rystes ved 50°C i en hydrogenatmosfære indtil reaktionen er fuldført, ca. 3 timer. Katalysatoren fjernes ved filtrering hvorefter , opløsningsmidlet afdestilleres. Remanensen omdannes til citrat saltet deraf som beskrevet foran. Udbyttet er næsten kvanti-10 tativt.Example 6 Tamoxifen (Z) (I) Dissolve 40.6 g (Z) triphenyl chloride VIII (X = Cl) in 1000 ml of ethanol and then 41.4 g of dry potassium carbonate 5 and 12 g of 5% palladium / carbon are added. The reaction mixture is shaken at 50 ° C in a hydrogen atmosphere until the reaction is complete, ca. 3 hours. The catalyst is removed by filtration and the solvent is distilled off. The residue is converted to the citrate salt thereof as described above. The yield is almost quantitative.

Eksempel 7 4-Klor-1,2-difenyl-1- {4 -[2-(N,N-dimetylamino)-ætoxy]-f enylj - ^^ 1-buten (Z) (trifenylkloridet VIII, X = Cl)_ 405 g trifenyldiol V suspenderes i 2500 ml toluen hvorpå 250 ml toluen afdestilleres for at tørre opløsningen. Blandingen afkøles under omrøring til 0°C. Under fortsat omrøring og idet temperaturen holdes på 0°C eller en smule derunder 2q tilsættes der 476 g tionylklorid af god kvalitet. Blandingen omrøres i 1 time ved 0°C og derefter får temperaturen lov til at stige til 22°C.Example 7 4-Chloro-1,2-diphenyl-1- {4 - [2- (N, N-dimethylamino) -ethoxy] -phenyl] -1H-butene (Z) (the triphenyl chloride VIII, X = Cl) 405 g of triphenyl diol V are suspended in 2500 ml of toluene and then 250 ml of toluene is distilled off to dry the solution. The mixture is cooled with stirring to 0 ° C. With continued stirring and keeping the temperature at 0 ° C or slightly below 2q, 476 g of good quality thionyl chloride is added. The mixture is stirred for 1 hour at 0 ° C and then allowed to rise to 22 ° C.

Derpå omrøres blandingen ved 80°C indtil reaktionen er fuldført, ca. 3 timer. Der tilsættes vand for at nedbryde 2,- overskydende tionylklorid og derefter 20%s n at ri umhy dr oxydopløsning for at frigøre produktet fra dets hydrokloridsalt.Then the mixture is stirred at 80 ° C until the reaction is complete, ca. 3 hours. Water is added to decompose 2, - excess thionyl chloride, and then 20% to obtain anhydrous oxide solution to release the product from its hydrochloride salt.

Det vandige lag kasseres. Toluenlaget vaskes med vand. Derefter sidestilleres opløsningsmidlet til frembringelse af (Z,E)-trifenylkloridet (Z:E = 7:3) i kvantitativt udbytte. Remanen-^ sen omkrystalliseres fra metanol. Der vindes 182 g (45%) ren (Z)-isomer.Discard the aqueous layer. The toluene layer is washed with water. Then, the solvent is juxtaposed to give the (Z, E) triphenyl chloride (Z: E = 7: 3) in quantitative yield. The residue is recrystallized from methanol. 182 g (45%) of pure (Z) isomer is obtained.

Tamoxifen (Z) (I) 182 g af (Z)-trifenylkloridet og 51 g natriumborhydrid opløses i 900 ml dimetylsulfoxyd og reaktionsblandingen holdes i 5 timer på 85°C. Der tilsættes vand hvorved produktet udfældes som et borkompleks. Bundfaldet frafiltreres og vaskes 23Tamoxifen (Z) (I) 182 g of the (Z) triphenyl chloride and 51 g of sodium borohydride are dissolved in 900 ml of dimethyl sulfoxide and the reaction mixture is kept at 85 ° C for 5 hours. Water is added to precipitate the product as a boron complex. The precipitate is filtered off and washed 23

DK 165785BDK 165785B

med vand. Derpå opløses bundfaldet i 1125 ml absolut ætanol og der tilsættes 225 ml koncentreret saltsyre. Blandingen omrøres i 2 timer ved 50°C hvorved komplekset nedbrydes. Opløsningsmidlet afdampes og derefter suspenderes produktet 5 i toluen. Der tilsættes 2M natriumhydroxydopløsning for at frigøre produktet fra sit hydrokloridsalt. Det vandige lag kasseres og toluenlaget vaskes med vand. Derefter afdampes opløsningsmidlet. Til sidst omdannes remanensen til citratsaltet deraf som beskrevet ovenfor. Udbyttet er næsten kvantita-10 tivt og smeltepunktet ca. 142°C.with water. The precipitate is then dissolved in 1125 ml of absolute ethanol and 225 ml of concentrated hydrochloric acid is added. The mixture is stirred for 2 hours at 50 ° C, which degrades the complex. The solvent is evaporated and then the product 5 is suspended in toluene. 2M sodium hydroxide solution is added to release the product from its hydrochloride salt. The aqueous layer is discarded and the toluene layer is washed with water. The solvent is then evaporated. Finally, the residue is converted to the citrate salt thereof as described above. The yield is almost quantitative and the melting point approx. 142 ° C.

Claims (2)

1. Fremgangsmåde til fremstilling af (Z)-l,2-difenyl-l-{4-[2-(N,N-dimetylamino)-ætoxy]-fenylj-l-buten (tamoxifen) med formel I eller et syreadditionssalt deraf 5 /CH3 0CHoCH,N^ 1 2 2 ^CH3 I 2 CH3 kendetegnet ved at et trifenylbutenderivat med formlen 15 ^CH.. OCH-CH^NC j I 2 *^CH3 fj O-r^-O CH Ϊη2χ hvor X er en funktionel gruppe såsom F, Cl, Br, I eller 25 $ -O-S-R II o hvor R er 4-tolyl eller metyl, reduceres med et metalhydrid-reduktionsmiddel såsom litiumaluminiumhydrid i f.eks. tetra-30 hydrofuran ved forhøjet temperatur, natriumborhydrid ved forhøjet temperatur eller i et organisk opløsningsmiddel, såsom dimethylsulfoxid, eller ved anvendelse af faseoverføringsteknik, hvor den organiske fase f.eks. er toluen, eller natrium-bis- (2-metoxyætoxy)-aluminiumdihydrid f.eks. i toluen ved for-35 højet temperatur. DK 165785B 2. (Z)-1,2-Difenyl-1-{4-[2-(Ν,Ν-dimetylamino)-ætoxy]- fenyl}·-!-butenderivat med formlen CH., OCH~CH~N^A process for the preparation of (Z) -1,2-diphenyl-1- {4- [2- (N, N-dimethylamino) -ethoxy] -phenyl] -1-butene (tamoxifen) of formula I or an acid addition salt thereof 5 / CH3 OCHoCH, N ^ 1 2 2 ^ CH3 I 2 CH3 characterized in that a triphenylbutene derivative of the formula 15 ^ CH .. OCH-CH ^ NC j I 2 * ^ CH3 fj Or ^ -O CH Ϊη2χ where X is a functional group such as F, Cl, Br, I or 25 $ -OSR II where R is 4-tolyl or methyl is reduced with a metal hydride reducing agent such as lithium aluminum hydride in e.g. tetrahydrofuran at elevated temperature, sodium borohydride at elevated temperature or in an organic solvent such as dimethyl sulfoxide, or using phase transfer technique, where the organic phase e.g. is toluene, or sodium bis (2-methoxyethoxy) aluminum dihydride e.g. in toluene at elevated temperature. 2. (Z) -1,2-Diphenyl-1- {4- [2- (Ν, Ν-dimethylamino) -ethoxy] -phenyl} -butan derivative of the formula CH ^ 5 I ^CH3 U oifo I ^ CH~X 10 2 O hvor X betegner F, Cl, Br, I eller -O-S-R, hvor R er 4-tolyl tt eller metyl til brug som udgangsmateriale ved fremgangsmåden 15 ifølge krav 1.Wherein X represents F, Cl, Br, I or -O-S-R, wherein R is 4-tolyl tt or methyl for use as the starting material of the method of claim 1.
DK236683A 1982-05-27 1983-05-26 PROCEDURE FOR THE PREPARATION OF TRIPHENYL BUTEN DERIVATIVES AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND INTERMEDIATES FOR USING THE PROCEDURE DK165785C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI821879A FI67538C (en) 1982-05-27 1982-05-27 PROCEDURE FOR FRAMSTATION OF AV (Z) -1,2-DIPHENYL-1- (4- (2- (N N-DIMETHYLAMINO) ETHOXY) PHENYL) -1-BUTEN
FI821879 1982-05-27

Publications (4)

Publication Number Publication Date
DK236683D0 DK236683D0 (en) 1983-05-26
DK236683A DK236683A (en) 1983-11-28
DK165785B true DK165785B (en) 1993-01-18
DK165785C DK165785C (en) 1993-06-14

Family

ID=8515594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK236683A DK165785C (en) 1982-05-27 1983-05-26 PROCEDURE FOR THE PREPARATION OF TRIPHENYL BUTEN DERIVATIVES AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND INTERMEDIATES FOR USING THE PROCEDURE

Country Status (7)

Country Link
JP (1) JPS58216129A (en)
AT (1) AT383344B (en)
DK (1) DK165785C (en)
FI (1) FI67538C (en)
HK (1) HK8389A (en)
NO (2) NO158096C (en)
ZA (1) ZA833803B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101492A1 (en) * 2003-05-19 2004-11-25 Orion Corporation Toremifene crystallization method

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
GB9207437D0 (en) * 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
EP0776661A1 (en) 1992-10-27 1997-06-04 Nippon Kayaku Kabushiki Kaisha Combined preparation of antiestrogen and glucocorticoid for the treatment of autoimmune disease
TW593256B (en) * 1999-11-16 2004-06-21 Hormos Medical Oy Ltd Triphenylalkene derivatives and their use as selective estrogen receptor modulators
CN106397226A (en) * 2016-04-19 2017-02-15 福安药业集团宁波天衡制药有限公司 Novel preparation method for tamoxifen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004101492A1 (en) * 2003-05-19 2004-11-25 Orion Corporation Toremifene crystallization method

Also Published As

Publication number Publication date
JPH0419973B2 (en) 1992-03-31
NO831874L (en) 1983-11-28
DK165785C (en) 1993-06-14
DK236683D0 (en) 1983-05-26
AT383344B (en) 1987-06-25
FI67538B (en) 1984-12-31
HK8389A (en) 1989-02-03
DK236683A (en) 1983-11-28
NO158096B (en) 1988-04-05
FI821879A0 (en) 1982-05-27
NO158096C (en) 1988-07-13
FI821879L (en) 1983-11-28
FI67538C (en) 1985-04-10
ZA833803B (en) 1984-02-29
NO1996002I1 (en) 1996-01-26
ATA192983A (en) 1986-11-15
JPS58216129A (en) 1983-12-15

Similar Documents

Publication Publication Date Title
FR2468591A1 (en) PROCESS FOR THE PREPARATION OF 2,5-BIS (2,2,2-TRIFLUORETHOXY) -N- (2-PIPERIDYLMETHYL) BENZAMIDE FROM 2,5-BIS (2,2,2-TRIFLUORETHOXY) BENZOIC ACID CHLORIDE
SU1106444A3 (en) Method of obtaining substituted dibenzooxipines or their salts or optical isomers
DK165785B (en) PROCEDURE FOR THE PREPARATION OF TRIPHENYL BUTEN DERIVATIVES AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND INTERMEDIATES FOR USING THE PROCEDURE
DK3250556T3 (en) PROCEDURES FOR THE PREPARATION OF COMPOUNDS, SUCH AS 3-ARYL BUTANALS THAT CAN BE USED FOR THE SYNTHESIS OF MEDETOMIDINE
CH640212A5 (en) Process for the preparation of 1-amino-3-aryloxy-2-propanol derivatives
US4304931A (en) Biphenylhydroxypropionic acid derivatives
CA3085475A1 (en) A process for the preparation of crisaborole
US4954659A (en) 1,4-bis (dihydroxyphenyl) butane and analogs
CN109942462B (en) Synthesis process of bambuterol hydrochloride
CH380134A (en) Process for the preparation of novel phenothiazine derivatives
CN112209841B (en) Synthesis method of terbutaline and application of terbutaline in preparation of terbutaline sulfate
CN108840788B (en) Preparation method of resveratrol
FR2549828A1 (en) Process for the preparation of trimethobenzamide hydrochloride
DK167920B1 (en) PROCEDURE FOR PREPARING A 2- (P-SUBSTITUTED PHENOXY) -2-ALKYLPROPIONIC ACID OR AN ALKYL ESTER THEREOF
FR2494584A1 (en) MEDICINES CONSISTING OF NEW 2-AMINOETHANOLS AND THEIR MANUFACTURING PROCESS
JPS6130653B2 (en)
JP2003137835A (en) Method for producing (r)-3-hydroxy-3-(2-phenyl)hexanoic acid
JPH0215050A (en) Production of optically active (s)-(-)-3-alkylamino-1-aryloxypropan-2-ol
JPS5951940B2 (en) Method for producing piperidinoalkanols
BE519400A (en)
BE538899A (en)
DD143249A1 (en) PROCESS FOR PREPARING 2-SUBSTITUTED 1- (2,6-D
BE563540A (en)
NO168470B (en) PROCEDURE FOR THE PREPARATION OF 5-HYDROXYDIPRAPHENONOIC ACID ADDITION SALTS THEREOF.
FR2599030A1 (en) PROCESS FOR PRODUCING ANTHRAQUINONES

Legal Events

Date Code Title Description
PUP Patent expired